{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T19:04:55Z","timestamp":1789326295536,"version":"build-2803163510"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,13]]},"DOI":"10.7759\/cureus.116183","type":"journal-article","created":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T18:44:59Z","timestamp":1789325099000},"source":"Crossref","is-referenced-by-count":0,"title":["Ischemic Stroke During Rivaroxaban Therapy: The Importance of Food-Dependent Absorption and Careful Assessment Before Antithrombotic Escalation"],"prefix":"10.7759","author":[{"given":"Mihail","family":"Petrov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teodora","family":"Sakelarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"Nalbantov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolay","family":"Velinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolay","family":"Gabrovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger CB","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, et al.. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011, 365:981-992. 10.1056\/NEJMoa1107039","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel MR","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, et al.. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011, 365:883-891. 10.1056\/NEJMoa1009638","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.032454","article-title":"Changing or retaining direct oral anticoagulant after ischemic stroke despite direct oral anticoagulant treatment","volume":"13","author":"Lin SY","year":"2024","unstructured":"Lin SY, Liao YT, Tang SC, Lin CC, Wang CC. Changing or retaining direct oral anticoagulant after ischemic stroke despite direct oral anticoagulant treatment. J Am Heart Assoc. 2024, 13:e032454. 10.1161\/JAHA.123.032454","journal-title":"J Am Heart Assoc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25700","article-title":"Ischemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation","volume":"87","author":"Seiffge DJ","year":"2020","unstructured":"Seiffge DJ, De Marchis GM, Koga M, et al.. Ischemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation. Ann Neurol. 2020, 87:677-687. 10.1002\/ana.25700","journal-title":"Ann Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.271","article-title":"Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation","volume":"170","author":"Hansen ML","year":"2010","unstructured":"Hansen ML, S\u00f8rensen R, Clausen MT, et al.. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Arch Intern Med. 2010, 170:1433-1441. 10.1001\/archinternmed.2010.271","journal-title":"Arch Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar JA","year":"2024","unstructured":"Joglar JA, Chung MK, Armbruster AL, et al.. 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024, 149:e1-e156. 10.1161\/CIR.0000000000001193","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-013-0100-7","article-title":"Clinical pharmacokinetic and pharmacodynamic profile of rivaroxaban","volume":"53","author":"Mueck W","year":"2014","unstructured":"Mueck W, Stampfuss J, Kubitza D, Becka M. Clinical pharmacokinetic and pharmacodynamic profile of rivaroxaban. Clin Pharmacokinet. 2014, 53:1-16. 10.1007\/s40262-013-0100-7","journal-title":"Clin Pharmacokinet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.20.7.864","article-title":"Measurements of acute cerebral infarction: a clinical examination scale","volume":"20","author":"Brott T","year":"1989","unstructured":"Brott T, Adams HP Jr, Olinger CP, et al.. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989, 20:864-870. 10.1161\/01.str.20.7.864","journal-title":"Stroke"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000082721.62796.09","article-title":"Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke","volume":"34","author":"Higashida RT","year":"2003","unstructured":"Higashida RT, Furlan AJ, Roberts H, et al.. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke. 2003, 34:e109-e137. 10.1161\/01.STR.0000082721.62796.09","journal-title":"Stroke"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.19.5.604","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"19","author":"van Swieten JC","year":"1988","unstructured":"van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988, 19:604-607. 10.1161\/01.str.19.5.604","journal-title":"Stroke"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000213964","article-title":"Anticoagulation strategies following breakthrough ischemic stroke while on direct anticoagulants: a meta-analysis","volume":"105","author":"Romoli M","year":"2025","unstructured":"Romoli M, Paciaroni M, Marrone N, et al.. Anticoagulation strategies following breakthrough ischemic stroke while on direct anticoagulants: a meta-analysis. Neurology. 2025, 105:e213964. 10.1212\/WNL.0000000000213964","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13820","article-title":"Development of immediate-release formulation with reliable absorption of rivaroxaban in various meal regimes","volume":"17","author":"Bos\u00e1k J","year":"2024","unstructured":"Bos\u00e1k J, \u0160\u00edma M, Krej\u010d\u00ed T, et al.. Development of immediate-release formulation with reliable absorption of rivaroxaban in various meal regimes. Clin Transl Sci. 2024, 17:e13820. 10.1111\/cts.13820","journal-title":"Clin Transl Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1570809","article-title":"Direct oral anticoagulation versus no therapy or antiplatelet for stroke prevention in patients with atrial fibrillation and history of intracranial hemorrhage: a systematic review and meta-analysis","volume":"12","author":"Sablot D","year":"2025","unstructured":"Sablot D, Gaillard N, Belahsen F, et al.. Direct oral anticoagulation versus no therapy or antiplatelet for stroke prevention in patients with atrial fibrillation and history of intracranial hemorrhage: a systematic review and meta-analysis. Front Med (Lausanne). 2025, 12:1570809. 10.3389\/fmed.2025.1570809","journal-title":"Front Med (Lausanne)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2025.3662","article-title":"Optimal antithrombotics for ischemic stroke and concurrent atrial fibrillation and atherosclerosis: a randomized clinical trial","volume":"82","author":"Okazaki S","year":"2025","unstructured":"Okazaki S, Tanaka K, Yazawa Y, et al.. Optimal antithrombotics for ischemic stroke and concurrent atrial fibrillation and atherosclerosis: a randomized clinical trial. JAMA Neurol. 2025, 82:1227-1234. 10.1001\/jamaneurol.2025.3662","journal-title":"JAMA Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14092914","article-title":"Challenges and opportunities of direct oral anticoagulant (DOAC) therapy in complex clinical scenarios: a comprehensive review and practical guide","volume":"14","author":"Miceli G","year":"2025","unstructured":"Miceli G, Ciaccio AM, Tuttolomondo A. Challenges and opportunities of direct oral anticoagulant (DOAC) therapy in complex clinical scenarios: a comprehensive review and practical guide. J Clin Med. 2025, 14:2914. 10.3390\/jcm14092914","journal-title":"J Clin Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2021-328391","article-title":"Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation","volume":"93","author":"Polymeris AA","year":"2022","unstructured":"Polymeris AA, Meinel TR, Oehler H, et al.. Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation. J Neurol Neurosurg Psychiatry. 2022, 93:588-598. 10.1136\/jnnp-2021-328391","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/532306-ischemic-stroke-during-rivaroxaban-therapy-the-importance-of-food-dependent-absorption-and-careful-assessment-before-antithrombotic-escalation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T18:45:00Z","timestamp":1789325100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/532306-ischemic-stroke-during-rivaroxaban-therapy-the-importance-of-food-dependent-absorption-and-careful-assessment-before-antithrombotic-escalation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,13]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.116183","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,13]]}}}